Taken together, these results suggest that GP73 targets the activation of the JAK2/STAT3 pathway to stimulate HUVEC growth and migration in vitro and promotes HCC tumor angiogenesis in vivo. This evidence concerns the gene JAK2 and hepatocellular carcinoma.